Clinical Trials Logo

Clinical Trial Summary

Eligible patients were randomized into two groups: Vitamin D group and Control group. Control group: routine treatment only, no additional vitamin D intervention therapy. Vitamin D group: In addition to the conventional treatment, additional intramuscular injection of vitamin D2 was given once every two weeks, each dose of 600,000 units, and the treatment lasted for 12 weeks. The primary and secondary outcomes will be collected.


Clinical Trial Description

Eligible patients with chronic intestinal failure/insufficiency were randomly assigned to one of two groups, Vitamin D group and Control group. Control group: routine treatment only, no additional vitamin D intervention therapy. Vitamin D group: In addition to the conventional treatment, additional intramuscular injection of vitamin D2 was given once every two weeks, each dose of 600,000 units, and the treatment lasted for 12 weeks. The primary and secondary outcomes will be collected. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06283615
Study type Interventional
Source Jinling Hospital, China
Contact Xuejin Gao, MD
Phone +86 18251937684
Email 547625433@qq.com
Status Recruiting
Phase N/A
Start date March 12, 2024
Completion date November 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04733066 - Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
Recruiting NCT05315765 - Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery
Recruiting NCT04577456 - Chyme Reinfusion for Type 2 Intestinal Failure N/A
Recruiting NCT03590418 - Microbial Diversity of Small Bowel Stoma Effluent and Colonic Faeces
Completed NCT05909228 - Bone Markers in Pediatric IF
Enrolling by invitation NCT06094504 - Spectral Lighting and Intestinal Failure N/A
Recruiting NCT05902104 - CGM-Assisted Management of PN
Completed NCT01386034 - Effects of Oral Citrulline on Protein Metabolism in Patients With Intestinal Failure (Citrugrêle 2) Phase 3
Recruiting NCT05868785 - Effect of Nocturnal Parenteral Nutrition on Bone Turnover and Energy Metabolism N/A
Terminated NCT01573286 - Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Phase 1/Phase 2
Active, not recruiting NCT00793195 - Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? Phase 2
Recruiting NCT06169774 - Video Training Supplementation for Patients Discharged on Home Parental Nutrition N/A
Completed NCT03222232 - Catheter Salvage in Intestinal Failure Patients N/A
Completed NCT06391762 - Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure
Completed NCT01986153 - Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients N/A
Completed NCT00995813 - Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure Phase 4
Recruiting NCT05813535 - 8.4% Sodium Bicarbonate Locks in Intestinal Failure Phase 2
Completed NCT03869957 - Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure N/A
Completed NCT00286039 - Plasma Citrulline Level in Relation to Absorptive Surface N/A
Completed NCT01946503 - Infant & Toddler Short Gut Feeding Outcomes Study